ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 86.4x | 18.6x | −0.5x | |
PEG Ratio | 13.25 | −0.29 | 0.00 | |
Price/Book | 5.7x | 1.2x | 2.6x | |
Price / LTM Sales | 10.0x | 0.8x | 3.3x | |
Upside (Analyst Target) | 2.2% | 12.4% | 45.6% | |
Fair Value Upside | Unlock | 14.3% | 4.9% | Unlock |